Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Site search

96° Sunny
- Malvern, AR (72104)
  Today
  
  Clear skies. Low around 70F. Winds light and variable..
  
  Tonight
  
  Clear skies. Low around 70F. Winds light and variable.
  
  Updated: September 17, 2026 @ 5:08 pm
- Full Forecast

Home
- Contact Us
- Subscribe
News
- Local News
Sports
Obituaries
Photos
- Photo Galleries
- Videos
e-Edition
Classifieds
- Place an ad
- Legal Notices
Archives
Readers Choice 2026

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Protagonist Therapeutics, Inc. - Common Stock (NQ:PTGX)

142.70 +4.01 (+2.89%)

Delayed Quote Updated: 3:40 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Protagonist Therapeutics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher ↗

October 11, 2021

Toward the end of trading on Monday, the Dow traded down 0.37% to 34,617.17 while the Nasdaq fell 0.05% to 34,617.14. The S&P 500 also fell, dropping 0.26% to 4,379.88. Let's look at what has happened...

Via Talk Markets

Topics Stocks

Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher ↗

October 11, 2021

Toward the end of trading Monday, the Dow traded down 0.37% to 34,617.17 while the NASDAQ fell 0.05% to 34,617.14. The S&P also fell, dropping 0.26% to 4,379.88. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 11, 2021

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares increased by 92.43% to $35.1 during Monday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

Where Protagonist Therapeutics Stands With Analysts ↗

October 11, 2021

Within the last quarter, Protagonist Therapeutics (NASDAQ:PTGX) has observ...

Via Benzinga

Mid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals ↗

October 11, 2021

Midway through trading Monday, the Dow traded up 0.50% to 34,920.55 while the NASDAQ rose 0.50% to 34,920.55. The S&P also rose, gaining 0.44% to 4,410.73. The U.S. has the...

Via Benzinga

Topics Stocks

28 Stocks Moving In Monday's Mid-Day Session ↗

October 11, 2021

Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical...

Via Benzinga

PTGX Stock: The FDA News That Has Protagonist Therapeutics Investors Cheering Today ↗

October 11, 2021

Protagonist Therapeutics (PTGX) stock is rocketing higher on Monday thanks to an update from the FDA concerning rusfertide clinical studies.

Via InvestorPlace

Protagonist Stock Flashes This Positive Signal After FDA Lifts Hold On Blood Diseases Drug ↗

October 11, 2021

Protagonist Therapeutics can now restart dosing patients in its rusfertide studies.

Via Investor's Business Daily

Protagonist Shares Almost Double As FDA Lifts Clinical Hold On Rusfertide Program ↗

October 11, 2021

The FDA has removed the full clinical hold on Protagonist Therapeutics Inc's (NASDAQ: PTGX) rusfertide clinical studies. The Company provided the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 11, 2021

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

Battered Protagonist Therapeutics Stock Is Primed For a Dip-Buy ↗

October 05, 2021

When Wall Street overreacts to a news catalyst, contrarian traders can step in to take advantage of a rare opportunity now with PTGX stock.

Via InvestorPlace

PROTAGONIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Protagonist on Behalf of Protagonist Stockholders and Encourages Investors to Contact the Firm

September 22, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

58 Biggest Movers From Yesterday ↗

September 24, 2021

Gainers MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares surged 73.4% to close at $12.80 on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362...

Via Benzinga

20 Stocks Moving in Wednesday's Pre-Market Session ↗

September 22, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 70.1% to $9.68 in pre-market trading following an announcement from management that the company entered into a revenue...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 21, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 30.95% to $8.08 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

32 Stocks Moving In Tuesday's Mid-Day Session ↗

September 21, 2021

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 177.4% to $39.83. Helbiz Media, the media arm of Helbiz announced a deal with Amazon Italy, a unit of Amazon.com. ReWalk...

Via Benzinga

48 Biggest Movers From Yesterday ↗

September 21, 2021

Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized...

Via Benzinga

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

Why Protagonist Therapeutics Stock Plunged Today ↗

September 20, 2021

The FDA has placed a clinical hold on testing of rusfertide.

Via The Motley Fool

Mid-Afternoon Market Update: Dow Tumbles 2.5%; BeyondSpring Shares Plunge ↗

September 20, 2021

Toward the end of trading Monday, the Dow traded down 2.57% to 33,696.98 while the NASDAQ fell 3.14% to 14,572.25. The S&P also fell, dropping 2.58% to 4,318.67. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 20, 2021

Gainers Atea Pharmaceuticals (NASDAQ:AVIR) shares increased by 13.83% to $29.86 during Monday's regular session. Trading volume for this security as of 12:30 EST is 3....

Via Benzinga

What 5 Analyst Ratings Have To Say About Protagonist Therapeutics ↗

September 20, 2021

Protagonist Therapeutics (NASDAQ:PTGX) has observed the following analyst ...

Via Benzinga

Mid-Day Market Update: Crude Oil Down 2%; Synlogic Shares Spike Higher ↗

September 20, 2021

Midway through trading Monday, the Dow traded down 1.51% to 34,063.71 while the NASDAQ fell 2.13% to 14,723.20. The S&P also fell, dropping 1.64% to 4,360.41. The U.S. has the...

Via Benzinga

Topics Stocks

35 Stocks Moving In Monday's Mid-Day Session ↗

September 20, 2021

Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Brooks Automation Divests Semiconductor Business For $3B ↗

September 20, 2021

Following the market opening Monday, the Dow traded down 1.42% to 34,093.46 while the NASDAQ fell 1.86% to 14,763.93. The S&P also fell, dropping 1.54% to 4,364.65. The U.S....

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2021 ↗

September 20, 2021

Upgrades For Methanex Corp (NASDAQ:

Via Benzinga

48 Biggest Movers From Friday ↗

September 20, 2021

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by...

Via Benzinga

PTGX Stock: Why Protagonist Therapeutics Is Plunging 60% Today ↗

September 17, 2021

Today, investors in Protagonist Therapeutics and PTGX stock have seen an absolutely massive decline due to an FDA hold of its clinical trial.

Via InvestorPlace

Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet ↗

September 17, 2021

Toward the end of trading Friday, the Dow traded down 0.47% to 4,587.22 while the NASDAQ fell 1.05% to 15,023.11. The S&P also fell, dropping 0.85% to 4,435.65. The U.S. has...

Via Benzinga

Topics Stocks

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Business
Local Events
Entertainment
Obituaries
Photos
Online Features

Services

Subscription Services
Submission Forms
Promote Your Event
Classifieds
Place an Ad
Email Alerts
Search
Weather

Malvern Daily Record

malvern-online.com
219 Locust Street
Malvern, AR 72104
Phone: 501-337-7523
Email: advertising@malvern-online.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Malvern, AR (72104)

Today

Tonight

Protagonist Therapeutics, Inc. - Common Stock (NQ:PTGX)

All News about Protagonist Therapeutics, Inc. - Common Stock

Sections

Services

Malvern Daily Record